BIENAIME JEAN JACQUES Insider Trades

Insider Trading History

Track insider trading activity for BIENAIME JEAN JACQUES. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Ascendis Pharma A/S
Ascendis Pharma A/S ASND
Director
Holding Value $87.5k 400 shares
Last Trade
May 26, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$95.1k 400 shares
$237.80
$218.84
Immunome
Immunome IMNM
Director
Holding Value $854k 43,415 shares
Last Trade
May 15, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$104k 5,000 shares
$20.70
$19.68
Keros Therapeutics
Keros Therapeutics KROS
Director
Holding Value $102k 9,450 shares
Last Trade
May 15, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$10.6k 1,000 shares
$10.58
$10.77
Keros Therapeutics
Keros Therapeutics KROS
Director
Holding Value $91k 8,450 shares
Last Trade
Apr 15, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$11.7k 1,000 shares
$11.70
$10.77
Ascendis Pharma A/S
Ascendis Pharma A/S ASND
Director
Holding Value $0 0 shares
Last Trade
Mar 23, 2026 Sale
$2M 9,160 shares
$218.06
$218.84
Immunome
Immunome IMNM
Director
Holding Value $756k 38,415 shares
Last Trade
Mar 11, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$21.6k 1,000 shares
$21.55
$19.68
Immunome
Immunome IMNM
Director
Holding Value $736k 37,415 shares
Last Trade
Mar 10, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$22.1k 1,000 shares
$22.12
$19.68
Keros Therapeutics
Keros Therapeutics KROS
Director
Holding Value $80.2k 7,450 shares
Last Trade
Mar 09, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$22.4k 2,000 shares
$11.21
$10.77
Immunome
Immunome IMNM
Director
Holding Value $371k 18,864 shares
Last Trade
Jun 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$181k 18,864 shares
$9.57
$19.68
Incyte
Incyte INCY
Director
Holding Value $2.11M 20,841 shares
Last Trade
Jun 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$646k 9,216 shares
$70.07
$101.24
Keros Therapeutics
Keros Therapeutics KROS
Director
Holding Value $113k 10,500 shares
Last Trade
Jun 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$156k 10,500 shares
$14.82
$10.77
Immunome
Immunome IMNM
Director
Holding Value $717k 36,415 shares
Last Trade
Jun 03, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$46.9k 5,000 shares
$9.38
$19.68
Immunome
Immunome IMNM
Director
Holding Value $618k 31,415 shares
Last Trade
Mar 25, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$54.2k 7,800 shares
$6.95
$19.68
Immunome
Immunome IMNM
Director
Holding Value $465k 23,615 shares
Last Trade
Mar 24, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$57.5k 7,000 shares
$8.21
$19.68
Immunome
Immunome IMNM
Director
Holding Value $327k 16,615 shares
Last Trade
Aug 16, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$97.6k 7,000 shares
$13.94
$19.68
Immunome
Immunome IMNM
Director
Holding Value $223k 11,333 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$182k 11,333 shares
$16.04
$19.68
Incyte
Incyte INCY
Director
Holding Value $1.27M 12,517 shares
Last Trade
Jun 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$750k 12,517 shares
$59.94
$101.24
Incyte
Incyte INCY
Director
Holding Value $1.86M 18,323 shares
Last Trade
Jun 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$170k 2,830 shares
$59.94
$101.24
Keros Therapeutics
Keros Therapeutics KROS
Director
Holding Value $190k 17,600 shares
Last Trade
Jun 03, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$857k 17,600 shares
$48.67
$10.77
Immunome
Immunome IMNM
Director
Holding Value $189k 9,615 shares
Last Trade
May 21, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$27.1k 2,000 shares
$13.57
$19.68

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up